Table 1.
Trial (Trial Period) |
Number of Animals | ASFV Strain (Genotype) |
Strain Characteristics |
Route of Infection |
Dose per Animal |
---|---|---|---|---|---|
T1 (0–8 dpi) |
n = 6 | Arm07/CBM/c2 (II) | highly virulent | i.m. | 103 TCID50 |
T2 (0–21 dpi) |
n = 7 | Pol18_28298_O111 (II) | moderately/highly virulent | i.n. | 103 HAD50 |
T3 (0–28 dpi) |
n = 6 | NH/P68 (I) | attenuated | i.m. | 103 TCID50 |
i.m.—intramuscular, i.n.—intranasal.